Ehlers-Danlos syndrome, fibronectinemic type
MeSH: C565600ORPHA: 755011 Treatment Available
Available Treatments (1)
| Drug | Form | Status | Countries | Lead Time |
|---|---|---|---|---|
| ascorbic acid | Oral tablet 500 mg, 1000 mg; IV injection 500 mg/mL; Powder for oral solution | FDA Approved, EMA Approved | 12 | 1d |
Classification & Codes
MeSH Code
C565600Orphanet Code
ORPHA:75501Ehlers-Danlos syndrome, fibronectinemic type
| MeSH | C565600 |
| Orphanet | ORPHA:75501 |
| Treatments | 1 drug(s) |
| Status | published |
Treatment Summary
Factual Authority
Last Updated3/20/2026
Clinical DataHPO · Orphanet
Drug DataFDA · EMA · CDSCO